Cargando…
Efficacy and risk of mRNA vaccination in patients with autoimmune inflammatory rheumatic diseases
Coronavirus disease 2019 (COVID-19), which spread worldwide from Wuhan, China, in 2019, appeared for a time to be overcome by the remarkable efficacy of mRNA vaccines; however, new variants of severe acute respiratory syndrome coronavirus 2 have emerged and remain rampant. The involvement of the vir...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816539/ https://www.ncbi.nlm.nih.gov/pubmed/36609472 http://dx.doi.org/10.1186/s41232-022-00247-1 |